BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Endothelial cell
,
Human chorionic gonadotropin
,
Clofibrate
,
rs7903146
,
FGF21
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
roferon a
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for roferon a
Explore Curated Studies Results
Literature
Most Relevant Literature
How to produce 'marketable and profitable results for the company': from viral interference to Rofer…
Efficacy of Pegylated Interferon Alpha-2a in Uveitic Macular Edema Refractory to Biologic Agents.
The effect of apatinib in the treatment of metastatic renal cell carcinoma: a case report and review…
Use of antiviral therapy in patients with chronic hepatitis C.
The value of Roferon-A combined with hepatic artery chemoembolization and portal vein chemotherapy a…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study of Avastin (Bevacizumab) Added to Interferon Alfa-2a (Roferon) Therapy in Patients With Meta…
Phase II Study Of Roferon and Accutane For Patients With T-Cell Malignancies
PEG-Intron For Chronic Myelogenous Leukemia Patients Unresponsive To Or Intolerant Of Roferon Or Int…
A Study of Continued Treatment Among Participants Who Have Responded to Peginterferon Alfa-2a (Pegas…
A Study of MabThera/Rituxan (Rituximab) Alone and in Combination With Roferon-A in Patients With Fol…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ